| Literature DB >> 34549988 |
Edoardo Piombo1, Ramesh R Vetukuri2, Anders Broberg3, Pruthvi B Kalyandurg2, Sandeep Kushwaha2,4, Dan Funck Jensen1, Magnus Karlsson1, Mukesh Dubey1.
Abstract
Dicer-like proteins (DCLs) play a vital role in RNA interference (RNAi), by cleaving RNA filament into small RNAs. Although DCL-mediated RNAi can regulate interspecific communication between pathogenic/mutualistic organisms and their hosts, its role in mycoparasitic interactions is yet to be investigated. In this study, we deleted dcl genes in the mycoparasitic fungus Clonostachys rosea and characterize the functions of DCL-dependent RNAi in mycoparasitism. Deletion of dcl2 resulted in a mutant with reduced secondary metabolite production, antagonism toward the plant-pathogenic fungus Botrytis cinerea, and reduced ability to control Fusarium foot rot disease on wheat, caused by Fusarium graminearum. Transcriptome sequencing of the in vitro interaction between the C. rosea Δdcl2 strain and B. cinerea or F. graminearum identified the downregulation of genes coding for transcription factors, membrane transporters, hydrolytic enzymes, and secondary metabolites biosynthesis enzymes putatively involved in antagonistic interactions, in comparison with the C. rosea wild-type interaction. A total of 61 putative novel microRNA-like RNAs (milRNAs) were identified in C. rosea, and 11 were downregulated in the Δdcl2 mutant. In addition to putative endogenous gene targets, these milRNAs were predicted to target B. cinerea and F. graminearum virulence factor genes, which showed an increased expression during interaction with the Δdcl2 mutant incapable of producing the targeting milRNAs. In summary, this study constitutes the first step in elucidating the role of RNAi in mycoparasitic interactions, with important implications for biological control of plant diseases, and poses the base for future studies focusing on the role of cross-species RNAi regulating mycoparasitic interactions. IMPORTANCE Small RNAs mediated RNA interference (RNAi) known to regulate several biological processes. Dicer-like endoribonucleases (DCLs) play a vital role in the RNAi pathway by generating sRNAs. In this study, we investigated a role of DCL-mediated RNAi in interference interactions between mycoparasitic fungus Clonostachys rosea and the two fungal pathogens Botrytis cinerea and Fusarium graminearum (here called mycohosts). We found that the dcl mutants were not able to produce 11 sRNAs predicted to finetune the regulatory network of genes known to be involved in production of hydrolytic enzymes, antifungal compounds, and membrane transporters needed for antagonistic action of C. rosea. We also found C. rosea sRNAs putatively targeting known virulence factors in the mycohosts, indicating RNAi-mediated cross-species communication. Our study expanded the understanding of underlying mechanisms of cross-species communication during interference interactions and poses a base for future works studying the role of DCL-based cross-species RNAi in fungal interactions.Entities:
Keywords: Clonostachys rosea; RNA interference; antagonism; biocontrol; gene regulation; mycoparasitism; small RNA
Mesh:
Substances:
Year: 2021 PMID: 34549988 PMCID: PMC8557909 DOI: 10.1128/Spectrum.01099-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
FIG 1Phenotypic characterizations of C. rosea WT, deletion, and complementation strains. (A) Growth rate of WT, dcl deletion, and complemented strains. Strains were inoculated on PDA medium and incubated at 25°C, and the growth rate was recorded 5 days postinoculation (dpi). Error bars represent standard deviations based on four biological replicates. (B) Conidiation of WT, dcl deletion, and complementation strains on PDA medium 24 dpi. Conidia were harvested in equal volumes of water and were counted using a Bright-Line Haemocytometer according to the instructions of manufacturer. Error bars represent standard deviations based on four biological replicates. (C) Deletion of dcl2 affects pigment production in C. rosea. Strains were inoculated on PDA medium and incubated at 25°C. The experiment was performed in four biological replicates, and photographs of representative plates were taken 16 dpi. (D) Dual culture assay to test antagonistic ability of C. rosea WT, deletion, and complementation strains against B. cinerea. Agar plugs of C. rosea strains (left side in the plate) and B. cinerea (right side in the plate) were inoculated on opposite sides in 9-cm-diameter agar plates, followed by incubation at 25°C. The growth rates (overgrowth) of C. rosea WT, deletion, and complementation strains on B. cinerea were measured from the point of mycelial contact. The experiment was performed in four replicates, and photographs of representative plates were taken 21 dpi of C. rosea strains. An arrowhead indicates the mycelial front of C. rosea strains. (E) In vivo assay to test the biocontrol ability of C. rosea strains against F. graminearum foot rot disease on wheat. Seeds were coated with C. rosea conidia and planted in moist sand together with a F. graminearum agar plug. Seedlings were harvested 21 dpi, and disease symptoms were scored on a scale from 0 to 4. The experiment was performed in five biological replicates with 15 plants in each replicate. Different letters indicate statistically significant differences based on Tukey HSD method at the 95% significance level.
FIG 2UHPLC-MS analysis of cultures of C. rosea WT and deletion strains. (A) PCA of UHPLC-MS data from analysis of metabolites produced by C. rosea WT and mutant (Δdcl1, Δdcl2, Δdcl1+, and Δdcl2+) strains. Shaded areas indicate 95% confidence regions. (B) Retention times, mass-to-charge ratios (m/z), extracted-ion chromatogram peak areas, and tentative identification by UHPLC-MS and UHPLC-MS/MS of 17 metabolites produced in significantly smaller amount in Δdcl2 mutants compared to the WT and restored in the compared Δdcl2+ strain (ANOVA FDR <0.01). The compound at 125.4 s was comparably underproduced and restored also in the Δdcl1 strains. Ions are [M+H]+ except for the compound at 55.1 s, which is [M+H-H2O]+. The peak areas shown are average peak areas × 10−3 with standard deviations in brackets. The heatmap is based on sum-normalized and 10-logaritmized peak areas. Labels in panel A: A, may also be dihydroepoxysorbicillinol; B, proposed to be four different isomers of dihydrosorbicillinol; C, has the same m/z as sorbicillinol but different MS/MS data; D, may also be bisvertinoquinol or isobisvertinol; E, may also be bislongiquinolide or bisorbicillinolide or trichodimerol or trichotetronine; and F, may also be isodihydrobisvertinol.
FIG 3Transcriptome analysis of C. rosea WT and dcl1 and dcl2 deletion strains during the interactions with B. cinerea (Bc) and F. graminearum (Fg). (A) Venn diagram showing the common and species-specific DEGs in the Δdcl1 mutant against B. cinerea and F. graminearum. (B) Venn diagram showing the common and species-specific DEGs in the Δdcl2 mutant against B. cinerea and F. graminearum. (C) Overlap between DEGs in the Δdcl1 and Δdcl2 mutants against B. cinerea. (D) Overlap between DEGs in Δdcl1 and Δdcl2 mutants against F. graminearum. (E) Gene Ontology terms enriched in the differentially expressed C. rosea genes during the interactions.
Number of differentially expressed genes in Δdcl1 and Δdcl2 mutants compared to wild-type C. rosea during the interaction with F. graminearum and B. cinerea
| Type or function | No. of genes up- or downregulated | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| Up | Down | Up | Down | Up | Down | Up | Down | |
| MFS transporters | 26 | 16 | 12 | 64 | 5 | 1 | 6 | 99 |
| ABC transporters | 14 | 0 | 10 | 6 | 1 | 0 | 4 | 3 |
| SM biosynthesis | 45 | 38 | 27 | 99 | 7 | 1 | 13 | 127 |
| Chitinases | 0 | 0 | 3 | 3 | 1 | 1 | 1 | 3 |
| Transcription factors | 24 | 6 | 31 | 28 | 5 | 1 | 17 | 56 |
| Gene silencing machinery | 4 | 0 | 4 | 1 | 0 | 0 | 1 | 3 |
Differential expression patterns of selected genes in C. rosea Δdcl1 and Δdcl2 mutant strains during interactions with B. cinerea or F. graminearum compared to those of WT C. rosea
| Gene ID | Log2FC expression | Comment(s) | |||
|---|---|---|---|---|---|
| Δ | Δ | Δ | Δ | ||
| Differentially expressed MFS transporter genes identical to previously characterized MFS transporters | |||||
| CRV2G00017900 | −0.36 |
| 0.23 |
| |
| CRV2G00017824 | 0.36 | −0.68 | 0.21 |
| |
| CRV2G00015530 | −0.21 | −1.89 | 0.09 |
| |
| CRV2G00015418 | 0.02 |
|
|
| |
| CRV2G00004817 | 0.53 |
|
|
| |
| CRV2G00002357 | −0.4 | −1.26 |
|
| |
| CRV2G00016200 | 0.12 | −0.69 |
|
| |
| CRV2G00004939 | 0.22 | −1.76 |
|
| |
| CRV2G00019617 | 1.94 | 4.06 |
|
| |
| CRV2G00011170 | 0.95 | 0.17 | 0.14 |
| |
| CRV2G00005334 | 0.05 | −5.44 |
|
| |
| Reduced expression of MFS transporters that were induced in | |||||
| CRV2G00004685 | 0.32 | −0.79 | 0.62 |
|
|
| CRV2G00005389 | −0.81 | −0.75 |
|
|
|
| CRV2G00018263 | −0.37 | −0.79 | −0.74 |
|
|
| CRV2G00011170 | −0.03 | −1.18 | 0.14 |
|
|
| CRV2G00012180 | 1.12 |
| −1.45 |
|
|
| CRV2G00015972 | −0.06 |
|
|
|
|
| CRV2G00004853 | 0.45 | −1.45 |
|
|
|
| CRV2G00004939 | 0.22 |
|
|
|
|
| CRV2G00018885 | −0.39 | −1.22 |
|
|
|
| Differentially expressed polyketide and nonribosomal peptide synthetase genes | |||||
| CRV2G00011222 | −0.67 | 0.01 | 0.03 |
|
|
| CRV2G00013582 | 0 | −1.43 | −0.03 |
|
|
| CRV2G00015413 | 0.75 |
|
|
|
|
| CRV2G00015415 | 1.09 |
|
|
|
|
| CRV2G00018696 | −0.92 | −0.63 | −0.13 |
|
|
| CRV2G00018222 | 0.03 | −1.43 |
|
|
|
| CRV2G00004952 | 0.11 |
| 0.74 |
|
|
| CRV2G00005605 | 0.65 |
|
|
|
|
| CRV2G00012656 | 0.18 |
|
|
|
|
| CRV2G00015275 | −0.15 | −0.7 | 0.76 |
|
|
| CRV2G00016915 | 0.67 |
|
|
|
|
| CRV2G00014896 | 0.25 | 1.44 | 1.26 |
|
|
| CRV2G00005211 | 0.26 |
|
|
| Indole |
| CRV2G00002084 |
| 0.12 |
| −0.84 | Terpene |
| Differentially expressed transcription factor genes identical to previously characterized transcription factors | |||||
| CRV2G00004759 | −0.69 | −0.32 |
| −1.02 | ID 60% with FGR27 |
| CRV2G00006707 | −0.01 | −0.9 |
| −1.31 | ID 73% with CCAAT-binding subunit HAP3 |
| CRV2G00015419 | 0.29 | −0.95 |
|
| ID 53% with sorbicillin regulator YPR2 |
| CRV2G00011734 | 0.32 |
| 0.56 | 1.41 | ID 79% with |
| CRV2G00011385 | 0.19 | −0.46 |
| 1.16 | ID 57% with CTF1 |
| CRV2G00016352 | 0.73 |
| 0.47 | 1.3 | ID 65–70% SUC1 |
| CRV2G00019080 |
|
| 1.16 |
| ID 65% with SUC1 |
| CRV2G00019116 | 0.9 |
| 1.01 |
| ID 70% SUC1 |
| CRV2G00016935 | −0.74 | −0.22 |
| −0.7 | ID 69% with |
| CRV2G00018531 | −0.21 | −0.48 |
| −1.35 | ID 61% with sterol uptake control 2 |
| CRV2G00019093 | −0.38 | 0.43 |
| −0.14 | ID 60% with GAL4 |
| Differentially expressed chitinases and | |||||
| CRV2G00001280 | −0.08 | −0.85 |
|
| Chitinase |
| CRV2G00003425 | −0.3 |
|
|
| Chitinase |
| CRV2G00018858 | −0.01 | −0.06 |
|
| Chitinase |
| CRV2G00017631 | −0.07 | 0.16 | 0.62 |
| Chitinase |
| CRV2G00006887 | 0.82 |
| 0.92 |
| Chitinase |
| CRV2G00011101 | −0.3 | −0.13 |
|
| Chitinase |
| CRV2G00002927 | −0.21 | −0.42 |
| −0.78 | NAG |
| CRV2G00012950 | −0.14 | −0.43 |
|
| NAG |
| Differentially expressed genes associated with gene silencing machinery | |||||
| CRV2G00000975 | 0.2 | 0.1 | 1.2 |
| Argonaute2-like |
| CRV2G00016556 | 0.2 |
| 0.4 | 1.3 | Chromatin remodeling protein |
| CRV2G00012165 | 0.2 |
| −0.4 |
| Histone deacetylase |
| CRV2G00007951 | 0.4 | 0.4 | 1 |
| Histone deacetylase |
| CRV2G00006603 | 0.9 |
|
|
| RNA helicase |
| CRV2G00007159 | 0.6 |
| 0.5 | 1 | RNA helicase |
| CRV2G00001612 | −0.6 | 0.1 |
|
| RNA helicase |
| CRV2G00012613 | −0.7 | 0.9 |
| 0.1 | RNA helicase |
| CRV2G00009762 | 0 | 0.9 |
| −0.6 | RNA-directed RNA polymerase |
Significant differences are indicated in boldface letters. FDR < 0.05 in combination with a log2 fold change (log2FC) of >1.5 or <−1.5 was considered to define differentially expressed genes. Bc, B. cinerea; Fc, F. graminearum.
FIG 4Expression of predicted C. rosea gene clusters of clonorosein, pks29, sorbicillin, and fumisoquins. Gene IDs in boldface letters indicate downregulated genes during Δdcl2 mutant-B. cinerea interactions. Underlining indicates downregulated genes during Δdcl2 mutant-F. graminearum interactions. Boldfacing and underlining indicates genes that were downregulated against both mycohosts. The gene names for the sorbicillin and fumisoquin gene clusters were assigned by comparison to Trichoderma reesei and Aspergillus fumigatus, respectively (63, 73). A minimum query coverage of 80% was required in the comparison, and the maximum E value was fixed at 1 × 107.
FIG 5sRNA characteristics in C. rosea wild-type (WT) and dcl deletion strains. (A and B) Length distribution (A) and 5′ end nucleotide preference (B) of nonstructural sRNAs produced by C. rosea WT and dcl deletion strains during the interactions with F. graminearum (Fg) and B. cinerea (Bc). Only sRNAs between 18 and 32 nt in length are considered.
Differentially expressed cro-mir’s, their lengths, and their loci of origin
| milRNA identifier | Sequence (5′–3′) | Length (nt) | Log2FC | Origin | |||
|---|---|---|---|---|---|---|---|
| RNA-seq | Stem-loop RT-qPCR | ||||||
| Δ | Δ | Δ | Δ | ||||
| cro-mir-1 |
| 18 | −7.90 | −7.15 | −8.22 | −9.43 | Intergenic |
| cro-mir-2 |
| 19 | −8.70 | −8.23 | −3.33 | −10.94 | Intergenic |
| cro-mir-3 |
| 19 | −8.28 | −7.23 | −5.85 | −2.16 | 3′ UTR |
| cro-mir-4 |
| 19 | −8.47 | −6.25 | −2.18 | −2.92 | 3′ UTR |
| cro-mir-5 |
| 21 | −3.52 | −2.61 | −3.54 | −1.31 | Intergenic |
| cro-mir-6 |
| 21 | −4.39 | −4.70 | −2.05 | −1.75 | Intergenic |
| cro-mir-9 |
| 21 | −3.88 | −3.22 | −2.87 | −2.71 | Promoter |
| cro-mir-10 |
| 20 | −3.80 | −2.59 | −3.43 | −3.21 | Promoter |
| cro-mir-11 |
| 19 | −5.22 | −4.68 | −5.31 | −3.05 | Promoter |
| cro-mir-13 |
| 19 | −7.92 | −7.74 | −5.64 | −6.07 | 3′ UTR |
| cro-mir-23 |
| 22 | +2.68 | +2.18 | −2.09 | −3.10 | Intergenic |
| cro-mir-36 |
| 19 | −7.30 | −6.21 | −4.26 | −3.50 | Intergenic |
nt, nucleotides; UTR, untranslated region; Bc, B. cinerea; Fc, F. graminearum.
Endogenous putative gene targets in C. rosea, their expression patterns, and their predicted functions
| milRNA identifier | Gene target | Expression log2FC | Target gene family | Characterized/putative function | |
|---|---|---|---|---|---|
| Δ | Δ | ||||
| cro-mir-3 | CRV2G00002264 |
|
| Serine/threonine-protein kinase (Gin4) | Septin ring assembly, intracellular signal transduction |
| cro-mir-5 | CRV2G00013335 |
|
| Unknown | Unknown function |
| cro-mir-5 | CRV2G00015277 |
|
| Transcription factor | 60S ribosome biogenesis |
| cro-mir-10 | CRV2G00015277 |
|
| Transcription factor | 60S ribosome biogenesis |
| cro-mir-11 | CRV2G00015277 |
|
| Transcription factor | 60S ribosome biogenesis |
| cro-mir-13 | CRV2G00001868 |
|
| Helicase | Chromatin remodeling |
| CRV2G00002266 |
|
| Transcriptional regulator | Regulates the expression of the Pmc1 ATPase Ca2+ pump | |
| cro-mir-36 | CRV2G00013380 |
|
| ATPase | ATPase activity |
| CRV2G00005499 |
|
| Unknown | Unknown function | |
| CRV2G00000111 |
|
| Unknown | Unknown function | |
| CRV2G00014914 |
| 0.82 | Oxidation-reduction process | Part of secondary metabolite BGC | |
| cro-mir-1 | CRV2G00003756 |
| 0.89 | tRNA ligase | Protein biosynthesis |
| cro-mir-2 | CRV2G00003756 |
| 0.89 | tRNA ligase | Protein biosynthesis |
| cro-mir-3 | CRV2G00008014 |
| 0.23 | GTPase-activating protein 2 | Signal transduction |
| cro-mir-6 | CRV2G00002043 |
| 0.99 | Transcription factor | Regulation |
| cro-mir-3 | CRV2G00009307 |
| 0.81 | Sterol | Cholesterol metabolic process |
| cro-mir-11 | CRV2G00009307 |
| 0.81 | Sterol | Cholesterol metabolic process |
| cro-mir-3 | CRV2G00011242 |
| 0.75 | Oxidoreductase | Oxidation-reduction |
| cro-mir-4 | CRV2G00011242 |
| 0.75 | Oxidoreductase | Oxidation-reduction |
| cro-mir-13 | CRV2G00004332 |
| 0.43 | GTP-binding protein | Ribosome biogenesis |
| cro-mir-1 | CRV2G00005300 | 0.69 |
| Unknown | Unknown function |
| cro-mir-4 | CRV2G00004339 | 0.48 |
| SNF2 RNA helicase | Chromatin remodeling |
| cro-mir-9 | CRV2G00004339 | 0.48 |
| SNF2 RNA helicase | Chromatin remodeling |
| cro-mir-10 | CRV2G00004339 | 0.48 |
| SNF2 RNA helicase | Chromatin remodeling |
| cro-mir-11 | CRV2G00000903 | 0.82 |
| Unknown | Unknown function |
| cro-mir-36 | CRV2G00000903 | 0.82 |
| Unknown | Unknown function |
| cro-mir-10 | CRV2G00011823 | 0.93 |
| Choline-sulfatase | Hydrolase activity |
| cro-mir-36 | CRV2G00011823 | 0.93 |
| Choline-sulfatase | Hydrolase activity |
| cro-mir-4 | CRV2G00012062 | −0.18 |
| Unknown | Unknown function |
| cro-mir-13 | CRV2G00012781 | 0.3 |
| Unknown | Unknown function |
Upregulated (FDR < 0.05 in combination with log2FC >1) gene targets are highlighted in boldface. Bc, B. cinerea; Fc, F. graminearum.
Most important cross-species putative gene targets in B. cinerea and F. graminearum, their expression pattern and putative function
| milRNA identifier | Gene target transcript ID | Locus ID (gene name) | Expression (log2FC) | Target gene family | Characterized or putative function |
|---|---|---|---|---|---|
|
| |||||
| cro-mir-1, cro-mir-2, and cro-mir-6 |
| Bcin_01g09230 ( | 3.53 | Protein kinase | Signal transduction |
| cro-mir-9 |
| Bcin_05g05430 | 3.38 | Phospholipid methyltransferase | Lipid metabolic process (membrane lipid biogenesis) |
| cro-mir-13 |
| Bcin_02g04090 | 2.9 | Fungal 1,3(4)-β- | Glucan catabolic process |
| cro-mir-13 and cro-mir-2 |
| Bcin_01g00360 ( | 2.74 | Squalene monooxygenase | Sterol biosynthetic process |
| cro-mir-4 |
| Bcin_12g00180 ( | 2.69 | Aspartic proteases of fungal origin | Proteolysis, induced during infection |
| cro-mir-5 |
| Bcin_04g06150 | 2.29 | Cyclase (Lanc-like super family) | Biosynthesis of lantibiotics |
| cro-mir-1 and cro-mir-2 |
| Bcin_07g01580 ( | 2.27 | GTP-binding protein | Ribosomal large subunit biogenesis |
| cro-mir-4 |
| Bcin_06g01930 ( | 1.87 | Chitin binding | Chitin recognition |
| cro-mir-5 |
| Bcin_01g06010 ( | 1.83 | Glycosylphosphatidylinositol-glucanosyltransferase | Fungal cell wall biosynthesis |
| cro-mir-5 |
| Bcin_03g02630 ( | 1.81 | Protein kinase | Signal transduction, virulence |
| cro-mir-36 |
| Bcin_02g06930 | 1.67 | 1,3-β- | Glucan biosynthesis |
| cro-mir-36 |
| BCIN_02g02410 | 1.61 | Glycosyl hydrolase | Fungal-type cell wall polysaccharide metabolic process |
| cor-mir-11 |
| BCIN_14g02820 | 1.57 | β-Glucan synthesis-associated protein | Fungal cell wall biosynthesis |
| cro-mir-11 |
| BCIN_05g00350 ( | 1.57 | NADPH oxidase (NOX) | Pathogenicity, fusion of conidial anastomosis tubes, and formation of sclerotia and conidia |
| cro-mir-4 |
| BCIN_01g03790 ( | 1.54 | Chitin synthase | Cell wall biosynthesis, development and pathogenicity |
| cro-mir-4 |
| BCIN_05g00540 ( | 1.47 | Protein kinase | Signal transduction b |
| cro-mir-13 and cro-mir-2 |
| BCIN_09g06130 ( | 1.4 | Tetraspanins | Appressorium development, host penetration |
| cro-mir-1 and cro-mir-2 |
| BCIN_12g05700 | 1.38 | Cyclases | Biosynthesis of lantibiotics |
| cro-mir-36 |
| BCIN_08g03180 | 1.26 | Transcription factor | Appressorium formation |
| cro-mir-36 |
| BCIN_07g04590 ( | 1.2 | Histidine-tRNA ligase | Translation, ribosomal structure, and biogenesis |
| cro-mir-4 and cro-mir-36 |
| BCIN_10g02810 ( | 1.13 | Bromodomain-containing protein | Chromatin remodeling |
| ro-mir-1 and cro-mir-2 |
| BCIN_09g01210 ( | 1.11 | Chitin synthase | Cell wall biosynthesis, virulence |
| cro-mir-13 |
| BCIN_16g01130 ( | 1.03 | Serine/threonine kinases | Conidial germination, growth, and virulence |
| cro-mir-5 |
| BCIN_08g03270 ( | 1.02 | Fungus-type vacuole membrane | Intracellular trafficking and secretion |
|
| |||||
| cro-mir-3 |
| FGSG_07067 | 1.41 | Transcription factor | Virulence |
| cro-mir-4 |
| FGSG_02083 | 1.02 | Transcription factor | Mycotoxin biosynthesis |
| cro-mir-5 |
| FGSG_00376 | 1.07 | Ubiquinone oxidoreductase | Virulence |
| cro-mir-5 |
| FGSG_13747 | 1.03 | Membrane transporter | Transmembrane transporter activity |
| cro-mir-5 |
| FGSG_07665 | 1.14 | Membrane transporter | Transmembrane transporter activity |
| cro-mir-1 and cro-mir-2 |
| FGSG_11973 | 1.44 | Membrane transporter | Transmembrane transporter activity |
| cro-mir-9 |
| FGSG_09686 | 1.58 | Vesicle-mediated transport | Intracellular trafficking and secretion |
| cro-mir-6 |
| FGSG_06384 | 1.11 | Vesicle-mediated transport | Intracellular trafficking and secretion |
FIG 6Transcriptome analysis of B. cinerea (Bc) and F. graminearum (Fg) during the interaction with dcl1 and dcl2 deletion strains compared to those of the WT. (A) Venn diagrams showing the overlap between upregulated and downregulated genes in the Δdcl1 and Δdcl2 strains during the interactions with B. cinerea compared to the WT. (B) Gene Ontology terms enriched in upregulated and downregulated genes in dcl2 deletion strains during the interactions with B. cinerea. (C) Venn diagrams showing the overlap between up- and downregulated genes in Δdcl1 and Δdcl2 strains during interactions with F. graminearum compared to the WT.
Differential expression patterns of selected genes in B. cinerea and F. graminearum during interaction with Δdcl1 and Δdcl2 mutants compared to those of wild-type C. rosea and the same mycohost
| GenBank accession no. | Locus tag (gene ID) | Gene function | Expression (log2FC) | Biological function | |
|---|---|---|---|---|---|
|
|
| ||||
|
| |||||
| | BCIN_02g08360 (bcfrq1) | Circadian oscillator | 1.05 |
| Virulence |
| | BCIN_05g00350 (bcnoxa) | NADPH oxidase complex | −0.39 |
| Virulence |
| | BCIN_12g03770 (bcnop53) | Pre-rRNA processing factor | 0.19 |
| Fungal development and pathogenesis |
| | BCIN_03g06840 (bcnoxr) | Regulatory subunit of NOX (NADPH oxidase regulator) | −0.01 |
| Differentiation and pathogenicity |
| | BCIN_03g02630 (bcste11) | MAPK triple kinase | 0.16 |
| Hyphal growth |
| | BCIN_06g00026 (mfsG) | Major facilitator superfamily transporter | −0.84 |
| Tolerance to glucosinolate-breakdown products, required for pathogenicity |
| | BCIN_14g03930 (bcltf1) | GATA transcription factor |
|
| Tolerance to oxidative stress, virulence |
| | BCIN_15g03390 (bcvel1) | Regulatory protein of the VELVET complex | 0.13 |
| Formation of oxalic acid, virulence |
| | BCIN_09g01620 (bccry2) | DNA photolyase | 1.74 |
| Negative regulation of filamentous growth and conidiation |
| | BCIN_01g06010 (bccrh) | Transglycosylase | 0.00 |
| Cell wall biogenesis, virulence |
| | BCIN_07g01300 (bcchsvii | Chitin synthase | 0.06 |
| Cell wall biogenesis, virulence |
| | BCIN_12g05360 (bcchsvi) | Chitin synthase | 0.04 |
| Cell wall biogenesis, Virulence |
| | BCIN_12g05370 (bcchsv) | Chitin synthase | −0.12 |
| Cell wall biosynthesis |
| | BCIN_01g03790 (bcchsiv) | Chitin synthase | −0.15 |
| Cell wall biosynthesis |
| | BCIN_03g09000 | Septin GTPase |
|
| Cytoskeleton-dependent cytokinesis (septin ring) |
| | BCIN_07g02420 | MFS transporters | −0.83 |
| Xenobiotic transport |
| | BCIN_11g00800 | Protein kinase CK2 | 1.43 |
| Regulates various cellular processes |
| | BCIN_01g01760 | Chitinase activity | 0.06 |
| Cell wall biosynthesis |
| | BCIN_12g03920 | Chitin binding | 0.35 |
| Chitin recognition |
| | BCIN_01g02970 | Chitin binding | 0.00 |
| Chitin recognition |
| | BCIN_06g01930 (bcgo1) | Chitin binding | −0.07 |
| Chitin recognition |
| | BCIN_01g00360 (bcerg1) | Squalene monooxygenase |
|
| Sterol biosynthetic process |
|
| |||||
| | FGSG_00324 ( | Transcription factor | +1.05 |
| Fungal development and pathogenicity |
| | FGSG_00729 ( | Transcription factor | +0.99 |
| Virulence |
| | FGSG_10057 ( | Transcription factor | +1.44 |
| Growth and pathogenicity |
| | FGSG_08617 ( | Transcription factor | +1.46 |
| Virulence |
| | FGSG_04580 ( | ABC pleiotropic drug resistance transporter |
| 0.40 | Virulence and tolerance to benalaxyl |
| | FGSG_11028 | Multidrug resistance-associated protein |
| Nivalenol biosynthesis | |
| | FGSG_05898 ( | Fungal phospholipase C | +1.31 |
| Development, pathogenicity, and stress responses |
| | FGSG_07133 ( | Transcription factor | +1.18 |
| Virulence |
| | FGSG_07928 ( | Transcription factor | +1.29 |
| Virulence |
| | FGSG_00007 | Cytochrome P450 |
|
| DON biosynthesis |
| | FGSG_00071 ( | Cytochrome P450 |
| −1.38 | DON biosynthesis |
| | FGSG_03534 ( | 15- |
|
| DON biosynthesis |
| | FGSG_03535 ( | Trichodiene oxygenase |
|
| DON biosynthesis |
| | FGSG_03537 ( | Trichodiene synthase |
|
| DON biosynthesis |
| | FGSG_03536 ( | Transcription factor | −1.15 |
| DON biosynthesis |
| | FGSG_03539 ( | TRI9 protein | −1.42 |
| DON biosynthesis |
| | FGSG_03543 ( | Mala s 1-allergenic | − |
| DON biosynthesis |
| | FGSG_03542 | Cytochrome P450 | −1.81 |
| DON biosynthesis |
| | FGSG_08196 | Peptidase A4 |
|
| Highly induced in mycotoxin-inducing media |
| | FGSG_03065 ( | Phytoene dehydrogenase | −0.80 |
| Neurosporaxanthin and torulene BGC |
| | FGSG_03071 | FAD-dependent oxidoreductase | −1.74 |
| Neurosporaxanthin and torulene BGC |
| | FGSG_03066 ( | al-2/carRA phytoene synthase | −0.77 |
| Neurosporaxanthin and torulene BGC |
| | FGSG_10460 ( | Enoyl reductase | 1.10 |
| Fusarielin BGC |
| | FGSG_10462 ( | Aldose 1‐epimerase |
|
| Fusarielin BGC |
| | FGSG_10463 ( | Esterase |
|
| Fusarielin BGC |
| | FGSG_10464 ( | Polyketide synthase |
|
| Fusarielin BGC |
Significant differences (FDR < 0.05 and log2FC > 1.5 or <−1.5) are highlighted in boldface letters.